Wekerle, H.: Tackling multiple sclerosis. Nature 420 (6911), pp. 39 - 40 (2002)

Wiendl, H.; Hohlfeld, R.: Therapeutic approaches in multiple sclerosis - Lessons from failed and interrupted treatment trials. Biodrugs 16 (3), pp. 183 - 200 (2002)

Wiendl, H.; Malotka, J.; Holzwarth, B.; Weltzien, H. U.; Wekerle, H.; Hohlfeld, R.; Dornmair, K.: An autoreactive γδ TCR derived from a polymyositis lesion. Journal of Immunology 169 (1), pp. 515 - 521 (2002)

Ziemssen, T.; Kümpfel, T.; Klinkert, W. E. F.; Neuhaus, O.; Hohlfeld, R.: Glatiramer acetate-specific T-helper 1-and 2-type cell lines produce BDNF: Implications for multiple sclerosis therapy. Brain 125, pp. 2381 - 2391 (2002)

Ziemssen, T.; Neuhaus, O.; Farina, C.; Hartung, H. P.; Hohlfeld, R.: Treatment of multiple sclerosis with glatiramer acetate - new information about its mechanisms of action, pharmacokinetics, adverse effects and clinical studies. Nervenarzt 73 (4), pp. 321 - 331 (2002)

Ziemssen, T.; Neuhaus, O.; Hohlfeld, R.: Risk-benefit assessment of glatiramer acetate in multiple sclerosis. Drug Safety 24 (13), pp. 979 - 990 (2002)

Daubenberger, C. A.; Nickel, B.; Hübner, B.; Siegler, U.; Meinl, E.; Pluschke, G.: Herpesvirus saimiri transformed T cells and peripheral blood mononuclear cells restimulate identical antigen-specific human T cell clones. Journal of Immunological Methods 254 (1-2), pp. 99 - 108 (2001)

Egg, R.; Reindl, M.; Deisenhammer, F.; Linington, C.; Berger, T.: Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Multiple Sclerosis Journal 7 (5), pp. 285 - 289 (2001)

Farina, C.; Bergh, F. T.; Albrecht, H.; Meinl, E.; Yassouridis, A.; Neuhaus, O.; Hohlfeld, R.: Treatment of multiple sclerosis with Copaxone (COP) Elispot assay detects COP-induced interleukin-4 and interferon-γ response in blood cells. Brain 124, pp. 705 - 719 (2001)

Flügel, A.; Bradl, M.; Kreutzberg, G. W.; Graeber, M. B.: Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. Journal of Neuroscience Research 66 (1), pp. 74 - 82 (2001)

Flugel, A.; Matsumuro, K.; Neumann, H.; Klinkert, W. E. F.; Birnbacher, R.; Lassmann, H.; Otten, U.; Wekerle, H.: Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: Inhibition of monocyte transendothelial migration. European Journal of Immunology 31 (1), pp. 11 - 22 (2001)

Hackstein, H.; Bitsch, A.; Bohnert, A.; Hofmann, H.; Weber, F.; Ohly, A.; Linington, C.; Maurer, M.; Poser, S.; Rieckmam, P. et al.; Bein, G.: Analysis of interleukin-4 receptor α chain variants in multiple sclerosis. Journal of Neuroimmunology 113 (2), pp. 240 - 248 (2001)

Iglesias, A.; Bauer, J.; Litzenburger, T.; Schubart, A.; Linington, C.: T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36 (2), pp. 220 - 234 (2001)

Medana, I.; Martinic, M. A.; Wekerle, H.; Neumann, H.: Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. American Journal of Pathology 159 (3), pp. 809 - 815 (2001)

Meinl, E.; Derfuss, T.; Pirzer, R.; Blank, N.; Lengenfelder, D.; Blancher, A.; Le Deist, F.; Fleckenstein, B.; Hivroz, C.: Herpesvirus saimiri replaces ZAP-70 for CD3- and CD2-mediated T cell activation. The Journal of Biological Chemistry 276 (40), pp. 36902 - 36908 (2001)

Schröder, G.; Hammer, M.; Risch, K.; Flügel, A.; Brock, J.; Lehmann, M.; Ritter, T.; Volk, H.-D.: Visualization of alloantigen-specific, EGFP-engineered T lymphocytes in a rat kidney transplantation model. Transplantation Proceedings 33 (1-2), pp. 607 - 608 (2001)

Wiegers, G. J.; Stec, I. E. M.; Klinkert, W. E. F.; Linthorst, A. C. E.; Reul, J.: Bidirectional effects of corticosterone on splenic T-cell activation: Critical role of cell density and culture time. Neuroendocrinology 73 (2), pp. 139 - 148 (2001)

Hohlfeld, R.; Kerschensteiner, M.; Stadelmann, C.; Lassmann, H.; Wekerle, H.: The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis. Journal of Neuroimmunology 107 (2), pp. 161 - 166 (2000)

Meinl, E.; Hohlfeld, R.: T cell transformation with Herpesvirus saimiri: A tool for neuroimmunological research. Journal of Neuroimmunology 103 (1), pp. 1 - 7 (2000)

Stefferl, A.; Schubart, A.; Storch, M.; Amini, A.; Mather, I.; Lassmann, H.; Linington, C.: Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. The Journal of Immunology 165 (5), pp. 2859 - 2865 (2000)

Bradl, M.; Bauer, J.; Inomata, T.; Zielasek, J.; Nave, K. A.; Toyka, K.; Lassmann, H.; Wekerle, H.: Transgenic Lewis rats overexpressing the proteolipid protein gene: Myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathologica 97 (6), pp. 595 - 606 (1999)

Haase, C. G.; Faustmann, P. M.; Diener, H. C.: Acute disseminated encephalomyelitis (ADEM). Aktuelle Neurologie 26 (2), pp. 68 - 71 (1999)

Haase, C. G.; Hohlfeld, R.: Knochenmark- und Stammzelltransplantation bei multipler Sklerose? Nervenarzt 70 (2), pp. 178 - 181 (1999)

Hohlfeld, R.: Therapeutic strategies in multiple sclerosis. I. Immunotherapy. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 354 (1390), pp. 1697 - 1710 (1999)

Kerschensteiner, M.; Gallmeier, E.; Behrens, L.; Vargas-Leal, V.; Misgeld, T.; Klinkert, W. E. F.; Kolbeck, R.; Hoppe, E.; Oropeza-Wekerle, R. L.; Bartke, I. et al.; Stadelmann, C.; Lassmann, H.; Wekerle, H.; Hohlfeld, R.: Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation? Journal of experimental medicine: JEM 189 (5), pp. 865 - 870 (1999)

Reindl, M.; Linington, C.; Brehm, U.; Egg, R.; Dilitz, E.; Deisenhammer, F.; Poewe, W.; Berger, T.: Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study. Brain 122, pp. 2047 - 2056 (1999)

Wiendl, H.; Neuhaus, O.; Stefan, H.: Treatment of Rasmussen's encephalitis. Deutsche Medizinische Wochenschrift 124 (31-32), pp. 937 - 939 (1999)

Wilharm, E.; Tschopp, J.; Jenne, D. E.: Biological activities of granzyme K are conserved in the mouse and account for residual Z-Lys-SBzl activity in granzyme A-deficient mice. FEBS Letters 459 (1), pp. 139 - 142 (1999)

Bauer, J.; Bradl, M.; Hickey, W. F.; Forss-Petter, S.; Breitschopf, H.; Linington, C.; Wekerle, H.; Lassmann, H.: T-cell apoptosis in inflammatory brain lesions - Destruction of T cells does not depend on antigen recognition. American Journal of Pathology 153 (3), pp. 715 - 724 (1998)

Behrens, L.; Kerschensteiner, M.; Misgeld, T.; Goebels, N.; Wekerle, H.; Hohlfeld, R.: Human muscle cells express a functional costimulatory molecule distinct from B7,1 (CD80) and B7,2 (CD86) in vitro and in inflammatory lesions. Journal of Immunology 161 (11), pp. 5943 - 5951 (1998)

Dang, T.; Goebels, N.; Walther, E. U.; Hohlfeld, R.: Treatment of relapsing-remitting multiple sclerosis with copolymer-1 (Glatirameracetate). Aktuelle Neurologie 25 (4), pp. 159 - 164 (1998)

Litzenburger, T.; Fässler, R.; Bauer, J.; Lassmann, H.; Linington, C.; Wekerle, H.; Iglesias, A.: B lymphocytes producing demyelinating autoantibodies: Development and function in gene-targeted transgenic mice. Journal of experimental medicine: JEM 188 (1), pp. 169 - 180 (1998)

Storch, M. K.; Stefferl, A.; Brehm, U.; Weissert, R.; Wallstrom, E.; Kerschensteiner, M.; Olsson, T.; Linington, C.; Lassmann, H.: Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathology 8 (4), pp. 681 - 694 (1998)

Utans-Schneitz, U.; Lorez, H.; Klinkert, W. E. F.; da Silva, J.; Lesslauer, W.: A novel rat CC chemokine, identified by targeted differential display, is upregulated in brain inflammation. Journal of Neuroimmunology 92 (1-2), pp. 179 - 190 (1998)

Wekerle, H.: The viral triggering of autoimmune disease. Nature Medicine 4 (7), pp. 770 - 771 (1998)

Burkett, P. R.; Pawlak, M.; Peters, A.; Kuchroo, V. K.: T cells and their subsets in autoimmunity. In: The autoimmune diseases, 6 Ed., pp. 91 - 116 (Eds. Rose, N. R.; Mackay, I. R.). Academic Press, London (2020)

Kawakami, N.: Intravital imaging of T cells within the spinal cord. In: Intravital Imaging of Dynamic Bone and Immune Systems. Methods in Molecular Biology, vol 1763, pp. 119 - 127 (Ed. Ishii, M.). Humana Press, New York (2018)

Burkett, P. R.; Lee, Y.; Peters, A.; Kuchroo, V. K.: Th17 and Th22 cells. In: Activation of the Immune System, Vol. 3, pp. 307 - 318 (Eds. Ratcliffe, M. J. H.; DeFranco, A.; Miyasaka, M.; Mosmann, T.). Academic Press (2016)

Kawakami, N.; Bartholomäus, I.; Pesic, M.; Kyratsous, N. I.: Intravital imaging of autoreactive T cells in living animals. In: Laboratory Methods in Cell Biology: Imaging, Vol. 113, pp. 149 - 168 (Ed. Conn, P. M.). Elsevier Academic Press, San Diego (2012)

Derfuss, T.; Arbusow, V.; Strupp, M.; Brandt, T.; Theil, D.: The presence of lytic HSV-1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia. In: Basic and Cinical Aspects of Vertigo and Dizziness, Vol. 1164, pp. 300 - 304 (Eds. Strupp, M.; Büttner, U.; Cohen, B.). Blackwell Publishing, Oxford (2009)

Bradl, M.; Dornmair, K.; Hohlfeld, R.: New tools for investigating the immunopathogenesis of MS: Principles and applications. In: Multiple Sclerosis: A Comprehensive Text, pp. 284 - 299 (Eds. Raine, C. S.; McFarland, H. F.; Hohlfeld, R.). Saunders, Elsevier, Edinburgh (2008)

Wekerle, H.; Flügel, A.: Demyelinating diseases: Immunological mechanisms in the pathogenesis of multiple Sclerosis. In: Molecular Neurology, pp. 475 - 497 (Ed. Waxman, S. G.). Elsevier, Amsterdam (2007)

Meinl, E.; Voltz, R.: Immunpathogenese der Multiplen Sklerose. In: Multiple Sklerose, pp. 43 - 54 (Eds. Schmidt, R. M.; Aktas, O.; Hoffmann, F. A.). Urban & Fischer, München, Jena (2006)

Wekerle, H.: Breaking Ignorance: The Case of the Brain. In: Current Concepts in Autoimmunity, pp. 25 - 50 (Eds. Radbruch, A.; Lipsky, P.). Springer, Berlin-Heidelberg (2006)

Jenne, D. E.: Peutz-Jeghers Syndrome. In: Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine (Eds. Ganten, D.; Ruckpaul, K.; Birchmeier, W.; Epplen, J. T.; Genser, K. et al.). Springer, Berlin, Heidelberg (2004)

Ziemssen, T.: Neuroprotection and glatiramer acetate: The possible role in the treatment of Multiple Sclerosis. In: Frontiers in Clinical Neuroscience: Neurodegeneration and Neuroprotection, pp. 111 - 134 (Eds. Vecsei, L.; Lajtha, A.). Kluwer Academic/ Plenum Publishing, New York (2004)

Dechant, G.; Neumann, H.: Neurotrophins. In: Molecular and Cellular Biology of Neuroprotection in the CNS, Vol. 513, pp. 303 - 334 (Ed. Alzheimer, C.). Kluwer/Plenum, New York (2002)

Derfuss, T.; Meinl, E.: Herpesviral proteins regulating apoptosis. In: Viral Proteins Counteracting Host Defenses, pp. 257 - 272 (Eds. Koszinowski, U. H.; Hengel, H.). Springer, Berlin (2002)

Meinl, E.; Fleckenstein, B.: T-cell transformation by Herpesvirus saimiri. In: Effects of microbes on the immune system, pp. 439 - 451 (Eds. Cunningham, M. W.; Fujinami, R. J.). Lippincott Williams & Wilkins, Philadelphia (2000)

Hohlfeld, R.; Wekerle, H.: Novel therapeutic approaches to autoimmunity. In: Autoimmune Diseases, 3 Ed., pp. 833 - 847 (Eds. Rose, N. R.; Mackay, I. R.). Academic Press, San Diego (1998)